Literature DB >> 3396959

Olsalazine and GI transit in UC.

S Meyers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3396959      PMCID： PMC1433639          DOI： 10.1136/gut.29.5.695-a

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties.

Authors:  H Sandberg-Gertzén; G Järnerot; W Kraaz
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

2.  Influence of olsalazine on gastrointestinal transit in ulcerative colitis.

Authors:  S S Rao; N W Read; C D Holdsworth
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

3.  Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.

Authors:  S Meyers; D B Sachar; D H Present; H D Janowitz
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

4.  Olsalazine in active ulcerative colitis.

Authors:  W S Selby; G D Barr; A Ireland; C H Mason; D P Jewell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.